Search

everythinglearnresearchcommunity

for

Search:↓

Understanding how different body systems interact can improve how we prevent or treat frailty in aging.

A woman's severe male hormone excess was caused by a small, hard-to-find ovarian tumor.

Low ferritin and high Anti TPO levels are linked to early hair greying.

Skin cells and certain hair follicle areas produce hemoglobin, which may help protect against oxidative stress like UV damage.

Low iron, low thyroid function, and stress are linked to excessive hair shedding in women.

Raising serum ferritin levels can improve symptoms like fatigue and hair loss, even if hemoglobin levels are normal.

Serum ferritin is a better indicator than hemoglobin for detecting low iron in women with chronic hair loss.

Hemoglobin α acts as an antioxidant in skin cells, especially protecting hair follicle stem cells from UV damage.

Low iron levels are linked to more hair loss in women with chronic hair shedding.

Iron profile tests are recommended for women with hair loss, as haemoglobin levels alone are not reliable.

Reticulocyte hemoglobin content is the best indicator of iron deficiency in women with diffuse non-scarring hair loss.

Reticulocyte hemoglobin content is the best indicator of iron deficiency causing hair loss in women.

People with normal hemoglobin but low ferritin experience more fatigue and certain symptoms like restless leg syndrome and dizziness.

B(III) blood type may have higher hemoglobin levels, but stress affects this, and hair iron levels correlate with hemoglobin in some blood types.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Pulse electric fields can control the release of growth factors and serotonin from platelet-rich plasma, offering a tailored approach to wound healing.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Testosterone undecanoate increases lean mass and causes various physical changes in female-to-male transsexuals.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Iron deficiency in women is common, often overlooked, and needs better recognition and treatment.

Artesunate is generally safe for severe malaria, but patients should be monitored for delayed anemia after treatment.

Severe iron deficiency lowers fertility in female rats.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Exercising women should be screened for anemia due to its prevalence and impact on performance.

Allethrin caused harmful effects and organ damage in rats, worsening with higher doses and longer exposure.

Hair loss in certain young mice is linked to a specific gene and can be caused by lack of iron.

LSCI-HR is reliable for monitoring blood flow in wound healing in mice.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

There is no clear link between low serum ferritin and chronic diffuse telogen hair loss.